Logo

bladder cancer

Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease

A suite of new studies examined how liquid biopsies could personalize treatment strategies in a range of cancer types.

European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response

The Eurostars grant will allow PamGene, Novigenix, and Radboud University Medical Center to develop a liquid biopsy test using mRNA and kinase activity profiling.

University of Birmingham, Nonacus to Develop Urine Cancer Liquid Biopsy Assay

The partners plan to offer the assay, which uses Nonacus' liquid biopsy sample prep platform and a biomarker panel validated by the university, by mid-2022.

Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data
Premium

A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.

Veracyte Bladder Cancer Test Receives Medicare Coverage

The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies.

Apr 16, 2021

OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence
Premium

Apr 12, 2021

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Apr 9, 2021

Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers

Apr 8, 2021

Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx
Premium

Mar 18, 2021

Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests
Premium

Mar 15, 2021

OncoDiag Raises $3M to Market Test for Early Detection of Recurrent Bladder Cancer

Feb 26, 2021

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year
Premium

Feb 18, 2021

Qiagen, Exosome Dx Building Urine-Based Digital PCR Workflow for FGFR Mutations in Bladder Cancer
Premium

Dec 22, 2020

Novigenix-Led Consortium Awarded Up to €1M to Develop Predictive Immune Checkpoint Inhibitor Test

Nov 6, 2020

Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests
Premium

Oct 12, 2020

Pacific Edge Diagnostics Receives Medicare Coverage for Bladder Cancer Test

Oct 1, 2020

Cancer Clues Gleaned from Somatic Mutation Patterns in Normal Bladders

Sep 9, 2020

NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities

Aug 12, 2020

GeneCentric Therapeutics, Janssen Partner to Uncover Bladder Cancer Biomarkers

Aug 6, 2020

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

May 19, 2020

Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Premium

May 11, 2020

Genetic Ancestry Linked to Differences in Molecular Features of Cancers

May 11, 2020

Decipher Bladder Cancer Test Determines Molecular Subtype Most Likely to Respond to Keytruda
Premium

Apr 6, 2020

MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
Premium

Jan 14, 2020

Celsee, Kindstar Ink Chinese Distribution Deal for Single-Cell Isolation Platform

Breaking News
The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.